Cargando…

MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT

A 17-year-old boy presented with a 2-week history of lower back pain, progressive gait difficulty and sensory deficit of bilateral lower limbs. Magnetic resonance imaging of neuroaxis showed intramedullary tumor with spinal cord expansion from Th12 to L2 and irregular areas of enhancement. Emergent...

Descripción completa

Detalles Bibliográficos
Autores principales: Takezaki, Tatsuya, Shinojima, Naoki, Kuroda, Junichiro, Yamamoto, Takahiro, Makino, Keishi, Yokoo, Hideaki, Mikami, Yoshiki, Mukasa, Akitake
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213101/
http://dx.doi.org/10.1093/noajnl/vdz039.111
_version_ 1783531729284235264
author Takezaki, Tatsuya
Shinojima, Naoki
Kuroda, Junichiro
Yamamoto, Takahiro
Makino, Keishi
Yokoo, Hideaki
Mikami, Yoshiki
Mukasa, Akitake
author_facet Takezaki, Tatsuya
Shinojima, Naoki
Kuroda, Junichiro
Yamamoto, Takahiro
Makino, Keishi
Yokoo, Hideaki
Mikami, Yoshiki
Mukasa, Akitake
author_sort Takezaki, Tatsuya
collection PubMed
description A 17-year-old boy presented with a 2-week history of lower back pain, progressive gait difficulty and sensory deficit of bilateral lower limbs. Magnetic resonance imaging of neuroaxis showed intramedullary tumor with spinal cord expansion from Th12 to L2 and irregular areas of enhancement. Emergent laminoplasty and biopsy was performed. Histopathological examination showed small atypical cells, but most cells had too much degeneration and necrosis to confirm the diagnosis definitively. Leptomeningeal dissemination caused conscious disturbance, nuchal rigidity and epilepsy. 2 weeks after decompression, we performed cordotomy again for advanced diagnosis, to be found diffuse midline glioma, H3K27M mutant by immunohistopathological examination and DAN sequence. He was treated with combination of whole brain and spine radiation therapy and chemotherapy with temozolomide and bevacizumab. He is still alive over 6 months. The clinical significance of H3K27M mutant in spinal gliomas is unclear. Further examinations are needed.
format Online
Article
Text
id pubmed-7213101
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-72131012020-07-07 MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT Takezaki, Tatsuya Shinojima, Naoki Kuroda, Junichiro Yamamoto, Takahiro Makino, Keishi Yokoo, Hideaki Mikami, Yoshiki Mukasa, Akitake Neurooncol Adv Abstracts A 17-year-old boy presented with a 2-week history of lower back pain, progressive gait difficulty and sensory deficit of bilateral lower limbs. Magnetic resonance imaging of neuroaxis showed intramedullary tumor with spinal cord expansion from Th12 to L2 and irregular areas of enhancement. Emergent laminoplasty and biopsy was performed. Histopathological examination showed small atypical cells, but most cells had too much degeneration and necrosis to confirm the diagnosis definitively. Leptomeningeal dissemination caused conscious disturbance, nuchal rigidity and epilepsy. 2 weeks after decompression, we performed cordotomy again for advanced diagnosis, to be found diffuse midline glioma, H3K27M mutant by immunohistopathological examination and DAN sequence. He was treated with combination of whole brain and spine radiation therapy and chemotherapy with temozolomide and bevacizumab. He is still alive over 6 months. The clinical significance of H3K27M mutant in spinal gliomas is unclear. Further examinations are needed. Oxford University Press 2019-12-16 /pmc/articles/PMC7213101/ http://dx.doi.org/10.1093/noajnl/vdz039.111 Text en © The Author(s) 2019. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Takezaki, Tatsuya
Shinojima, Naoki
Kuroda, Junichiro
Yamamoto, Takahiro
Makino, Keishi
Yokoo, Hideaki
Mikami, Yoshiki
Mukasa, Akitake
MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
title MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
title_full MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
title_fullStr MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
title_full_unstemmed MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
title_short MPC-16 RAPID PROGRESSIVE SPINAL DIFFUSE MIDLINE GLIOMA, A CASE REPORT
title_sort mpc-16 rapid progressive spinal diffuse midline glioma, a case report
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213101/
http://dx.doi.org/10.1093/noajnl/vdz039.111
work_keys_str_mv AT takezakitatsuya mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport
AT shinojimanaoki mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport
AT kurodajunichiro mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport
AT yamamototakahiro mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport
AT makinokeishi mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport
AT yokoohideaki mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport
AT mikamiyoshiki mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport
AT mukasaakitake mpc16rapidprogressivespinaldiffusemidlinegliomaacasereport